Senseonics Holdings (SENS) Net Equity Issued and Repurchased (2014 - 2026)

Senseonics Holdings' (SENS) quarterly Net Equity Issued and Repurchased came in at $3.5 million in Q1 2026, down 86.8% year-on-year from $26.5 million in Q1 2025, and up 114.68% on a QoQ basis from -$23.8 million in Q4 2025.

Senseonics Holdings (SENS) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has 11 years of Net Equity Issued and Repurchased data on file, last reported at $3.5 million in Q1 2026.

  • On a quarterly basis, Net Equity Issued and Repurchased fell 86.8% year-over-year to $3.5 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 79.94% decrease from a year earlier, with the FY2025 full-year figure at $28.3 million, up 642.36% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2026 stood at $3.5 million, up from -$23.8 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for SENS reached as high as $34.4 million in Q1 2023 and fell as low as -$27.0 million in Q2 2023.
  • Historically, Net Equity Issued and Repurchased has averaged $4.7 million across 5 years, with a median of $3.5 million in 2026.
  • On a YoY basis, Net Equity Issued and Repurchased climbed as much as 26356.0% in 2025 and fell as far as 16181.76% in 2025.
  • Year by year, Net Equity Issued and Repurchased stood at -$22.4 million in 2022, then slipped by 20.54% to -$27.0 million in 2023, then jumped by 100.55% to $148000.0 in 2024, then slumped by 16181.76% to -$23.8 million in 2025, then soared by 114.68% to $3.5 million in 2026.
  • Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $3.5 million in Q1 2026, -$23.8 million in Q4 2025, and $25.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Senseonics Holdings 203.54 Mn 139.22 Mn 6.94 Mn 3.49 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.49 Mn
Mar 31, 2026 3.49 Mn
Dec 31, 2025 -23.80 Mn
Dec 31, 2025 -23.80 Mn
Jun 30, 2025 25.67 Mn
Jun 30, 2025 25.67 Mn
Mar 31, 2025 26.46 Mn
Mar 31, 2025 26.46 Mn
Dec 31, 2024 148,000.00
Dec 31, 2024 148,000.00
Mar 31, 2024 100,000.00
Mar 31, 2024 100,000.00
Jun 30, 2023 -27.00 Mn
Jun 30, 2023 -27.00 Mn
Mar 31, 2023 34.40 Mn
Mar 31, 2023 34.40 Mn
Dec 31, 2022 -22.40 Mn
Dec 31, 2022 -22.40 Mn
Sep 30, 2022 26.40 Mn
Sep 30, 2022 26.40 Mn